"Neuroleptic malignant syndrome" (NMS) derives from the French "syndrome malin des neuroleptiques" and was first described in 1960 by Delay [1] and colleagues in association with haloperidol. It is a ...
Providing the latest peer-reviewed research on the clinical and biological aspects of treating this patient population with psychotropic medications, including side effects and interactions, standard ...
A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results